XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422L957. A total of 3 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $57,000 | -77.6% | 23,200 | -63.0% | 0.00% | – |
| Q2 2021 | $255,000 | +65.6% | 62,700 | +83.9% | 0.00% | – |
| Q1 2021 | $154,000 | +22.2% | 34,100 | +32.7% | 0.00% | – |
| Q4 2020 | $126,000 | +1045.5% | 25,700 | +1327.8% | 0.00% | – |
| Q3 2020 | $11,000 | +1000.0% | 1,800 | +500.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 23,200 | $57,000 | 0.00% |
| SIMPLEX TRADING, LLC | 108,500 | $452,000 | 0.00% |